FI881158A - Menetelmä terapeuttisesti käyttökelpoisen immunoglobuliinikonjugaatin valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisen immunoglobuliinikonjugaatin valmistamiseksi Download PDF

Info

Publication number
FI881158A
FI881158A FI881158A FI881158A FI881158A FI 881158 A FI881158 A FI 881158A FI 881158 A FI881158 A FI 881158A FI 881158 A FI881158 A FI 881158A FI 881158 A FI881158 A FI 881158A
Authority
FI
Finland
Prior art keywords
preparing
therapeutically useful
immunoglobulin conjugate
useful immunoglobulin
conjugate
Prior art date
Application number
FI881158A
Other languages
English (en)
Swedish (sv)
Other versions
FI881158A0 (fi
FI98706C (fi
FI98706B (fi
Inventor
Ian Farquhar Mckenzie
Geoffrey Allan Pietersz
Mark John Smyth
Original Assignee
Erba Carlo Spa
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa, Univ Melbourne filed Critical Erba Carlo Spa
Publication of FI881158A0 publication Critical patent/FI881158A0/fi
Publication of FI881158A publication Critical patent/FI881158A/fi
Application granted granted Critical
Publication of FI98706B publication Critical patent/FI98706B/fi
Publication of FI98706C publication Critical patent/FI98706C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI881158A 1987-03-11 1988-03-11 Menetelmä terapeuttisesti käyttökelpoisen immunoglobuliinikonjugaatin valmistamiseksi FI98706C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPI080387 1987-03-11
AUPI080387 1987-03-11
AUPI295587 1987-07-07
AUPI295587 1987-07-07

Publications (4)

Publication Number Publication Date
FI881158A0 FI881158A0 (fi) 1988-03-11
FI881158A true FI881158A (fi) 1988-09-12
FI98706B FI98706B (fi) 1997-04-30
FI98706C FI98706C (fi) 1997-08-11

Family

ID=25643244

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881158A FI98706C (fi) 1987-03-11 1988-03-11 Menetelmä terapeuttisesti käyttökelpoisen immunoglobuliinikonjugaatin valmistamiseksi

Country Status (29)

Country Link
US (1) US5798097A (fi)
JP (1) JP2736255B2 (fi)
KR (1) KR0130906B1 (fi)
CN (1) CN1045621C (fi)
AT (1) AT395375B (fi)
AU (1) AU622105B2 (fi)
BE (1) BE1001051A4 (fi)
CA (1) CA1329156C (fi)
CH (1) CH678815A5 (fi)
CZ (1) CZ161288A3 (fi)
DE (1) DE3808166C2 (fi)
DK (1) DK173792B1 (fi)
ES (1) ES2006109A6 (fi)
FI (1) FI98706C (fi)
FR (1) FR2612074B1 (fi)
GB (1) GB2203154B (fi)
GR (1) GR1000059B (fi)
HU (1) HU205266B (fi)
IE (1) IE64781B1 (fi)
IL (1) IL85688A0 (fi)
IT (1) IT8819746A0 (fi)
MY (1) MY103231A (fi)
NL (1) NL8800610A (fi)
NO (1) NO178954C (fi)
NZ (1) NZ223834A (fi)
PT (1) PT86960B (fi)
RU (1) RU2106147C1 (fi)
SE (1) SE503402C2 (fi)
YU (1) YU46858B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) * 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
CN100340291C (zh) * 1998-10-09 2007-10-03 路德维格癌症研究院 F1t4(VEGFR－3)作为肿瘤显像和抗肿瘤治疗的靶
AU2002216864A1 (en) * 2000-12-21 2002-07-01 Mcgill University Conjugates of antibodies and anticancer drugs
AU2002248372B8 (en) 2001-01-19 2008-03-20 Vegenics Limited FLT4(VEGFR-3) as a target for tumor imaging and anti-tumor therapy
CA2522700A1 (en) * 2003-04-18 2004-11-04 Cytovia, Inc. Methods of treating diseases responsive to induction of apoptosis and screening assays
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
PT2646470T (pt) 2010-11-30 2017-05-03 Hoffmann La Roche Anticorpos anti-recetor da transferrina de baixa afinidade e a sua utilização na transferência de scfv terapêuticos através da barreira hematoencefálica
CA2901226C (en) 2013-02-18 2020-11-17 Vegenics Pty Limited Vascular endothelial growth factor binding proteins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT346838B (de) * 1975-01-22 1978-11-27 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
AT343812B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven daunosaminylderivaten von anthracyclinonen
AT343811B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
GB1511680A (en) 1975-11-18 1978-05-24 Farmaceutici Italia Daunosaminyl anthracyclinones
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
US4950738A (en) * 1984-09-13 1990-08-21 Cytogen Corporation Amine derivatives of anthracycline antibiotics
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB8413464D0 (en) * 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
JPS61155334A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 殺細胞性修飾免疫グロブリン及びその製造方法
FR2584293B1 (fr) * 1985-07-04 1989-03-17 Ire Celltarg Sa Anticorps utiles comme agents de pilotage et conjugues les incorporant

Also Published As

Publication number Publication date
HUT46547A (en) 1988-11-28
FI881158A0 (fi) 1988-03-11
FR2612074A1 (fr) 1988-09-16
CH678815A5 (fi) 1991-11-15
NO178954C (no) 1996-07-10
CA1329156C (en) 1994-05-03
AT395375B (de) 1992-12-10
IL85688A0 (en) 1988-08-31
FI98706C (fi) 1997-08-11
YU48288A (en) 1989-08-31
SE8800886D0 (sv) 1988-03-11
DE3808166C2 (de) 1997-08-28
CZ281193B6 (cs) 1996-07-17
DK173792B1 (da) 2001-11-05
GB2203154A (en) 1988-10-12
GB8805865D0 (en) 1988-04-13
PT86960A (pt) 1988-04-01
JP2736255B2 (ja) 1998-04-02
KR880010775A (ko) 1988-10-24
SE8800886L (sv) 1989-09-12
NL195078C (fi) 2003-07-30
NZ223834A (en) 1990-05-28
IE64781B1 (en) 1995-09-06
NO881105L (no) 1988-09-12
CZ161288A3 (en) 1996-07-17
PT86960B (pt) 1992-06-30
DE3808166A1 (de) 1988-09-22
BE1001051A4 (fr) 1989-06-20
ATA67488A (de) 1992-05-15
ES2006109A6 (es) 1989-04-01
NL8800610A (nl) 1988-10-03
IT8819746A0 (it) 1988-03-11
YU46858B (sh) 1994-06-24
FR2612074B1 (fr) 1991-06-21
GR1000059B (el) 1990-06-27
GB2203154B (en) 1991-06-26
NO881105D0 (no) 1988-03-11
US5798097A (en) 1998-08-25
NO178954B (no) 1996-04-01
SE503402C2 (sv) 1996-06-10
DK131588A (da) 1988-09-12
RU2106147C1 (ru) 1998-03-10
HU205266B (en) 1992-04-28
FI98706B (fi) 1997-04-30
KR0130906B1 (ko) 1998-04-23
AU622105B2 (en) 1992-04-02
CN1045621C (zh) 1999-10-13
CN88101810A (zh) 1988-11-09
MY103231A (en) 1993-05-29
JPS63301832A (ja) 1988-12-08
DK131588D0 (da) 1988-03-11
GR880100148A (en) 1989-01-31
IE880701L (en) 1988-09-11
AU1288188A (en) 1988-09-15

Similar Documents

Publication Publication Date Title
FI102517B1 (fi) Menetelmä terapeuttisesti käyttökelpoisen immunokonjugaatin valmistamiseksi
FI104170B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-amidopyratsolijohdannaisten valmistamiseksi
NO178234C (no) Fremgangsmåte for fremstilling av et kimærisk antistoffmolekyl
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
FI98924B (fi) Menetelmä pigmentin valmistamiseksi
FI884193A (fi) Menetelmä valmistaa farmakologisesti arvokasta kefeemiyhdistettä
FI890286A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten dideoksikarbosyklisten nukleosidianalogien valmistamiseksi
PT84932A (en) Process for preparing immunoglobulin conjugates
FI906407A0 (fi) Menetelmä kestävän teräksen valmistamiseksi
FI883672A (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI884983A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten LL-E33288 kompleksi-disulfidianalogien valmistamiseksi
FI881158A (fi) Menetelmä terapeuttisesti käyttökelpoisen immunoglobuliinikonjugaatin valmistamiseksi
FI875102A0 (fi) Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
FI880842A (fi) Menetelmä kiteisen kefeemisulfaatin valmistamiseksi
FI92064C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-bentsopyranyylilaktaamien valmistamiseksi
FI911420A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI98459B (fi) Menetelmä terapeuttisesti käyttökelpoisten 5-etano-2,3,4,5-1H-2-bentsatsepin-7-olikarbamaattijohdannaisten valmistamiseksi
NO174200C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-imino-6-polyfluoralkoksybenzotiazol-forbindelser
NO173332C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive tetrahydrofuranderivater
FI884473A (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
PT87672A (pt) Process for preparing a pharmaceutical composition
FI881060A0 (fi) Menetelmä juustonmakuisen makuaineseoksen valmistamiseksi
FI891062A (fi) Menetelmä terapeuttisesti käyttökelpoisen sialosyyliglyseridin valmistamiseksi
FI885950A (fi) Menetelmä veteen liukenevan kationisen polymeerin valmistamiseksi
FI891205A (fi) Menetelmä terapeuttisesti käyttökelpoisen telluuripitoisen kompleksin valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Owner name: PHARMACIA & UPJOHN S.P.A.

GB Transfer or assigment of application

Owner name: PHARMACIA & UPJOHN S.P.A.

BB Publication of examined application
FG Patent granted

Owner name: PHARMACIA ITALIA S.P.A.

Owner name: THE UNIVERSITY OF MELBOURNE

MA Patent expired